Noninvasix is using light and sound to detect brain oxygenation levels in babies during active labor. As an adjunct to ineffective fetal heart rate monitors used in the majority of U.S. hospital births, Noninvasix’s pre-clinical patient monitoring system enables obstetricians to promptly recognize if a fetus is in distress and take immediate, corrective action. With its enhanced technology, the company aims to decrease the rate of cesarean sections and neurodevelopment issues associated with brain hypoxia.
In this podcast, Noninvasix CEO Dr. Graham Randall discusses the monitoring system and its technology.
